COREPHARMA FDA Approval ANDA 078482

ANDA 078482

COREPHARMA

FDA Drug Application

Application #078482

Documents

Letter2008-08-05

Application Sponsors

ANDA 078482COREPHARMA

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORAL25MG0EPLERENONEEPLERENONE
002TABLET;ORAL50MG0EPLERENONEEPLERENONE

FDA Submissions

ORIG1AP2008-07-30
LABELING; LabelingSUPPL3AP2013-07-11STANDARD
LABELING; LabelingSUPPL4AP2015-09-21STANDARD

Submissions Property Types

SUPPL3Null15
SUPPL4Null7

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

CHARTWELL RX
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 78482
            [companyName] => CHARTWELL RX
            [docInserts] => ["",""]
            [products] => [{"drugName":"EPLERENONE","activeIngredients":"EPLERENONE","strength":"25MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"EPLERENONE","activeIngredients":"EPLERENONE","strength":"50MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"EPLERENONE","submission":"EPLERENONE","actionType":"25MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"EPLERENONE","submission":"EPLERENONE","actionType":"50MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.